EXEL EXELIXIS, INC.
Nasdaq · SEC CIK 939767 · EDGAR
- Bought, last 12 months
- $1.19M 1 purchases by 1 insiders
- Sold, last 12 months
- $42.24M 24 sales by 12 insiders
- Filings on record
- 313 since 2021-07-08, latest 2026-08-12 19:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Aftab Dana | EVP, Research, Development | — | $7.70M |
| Haley Patrick J. | EVP, Commercial | — | $7.60M |
| Smith Julie | Dir | — | $4.69M |
| WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| Senner Christopher J. | EVP, CFO | — | $4.56M |
| PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| POSTE GEORGE | Dir | — | $2.74M |
| Beckerle Mary C | Dir | — | $1.93M |
| Oliver Bob | Dir | — | $1.33M |
| Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Transactions 443
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-04 | 2024-05-31 | EXEL | Oliver Bob | Dir | A - Grant | $0.00 | +18.8K | 37.0K | +104% | $0 | |
| D | 2024-06-04 | 2024-05-31 | EXEL | Smith Julie | Dir | A - Grant | $0.00 | +10.0K | 15.5K | +184% | $0 |
| 2024-06-04 | 2024-05-31 | EXEL | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +18.8K | 1.28M | +1% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | Eckhardt Sue Gail | Dir | A - Grant | $0.00 | +18.8K | 34.3K | +122% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | Heyman Tomas J. | Dir | A - Grant | $0.00 | +18.8K | 37.0K | +104% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | POSTE GEORGE | Dir | A - Grant | $0.00 | +18.8K | 232.7K | +9% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | Beckerle Mary C | Dir | A - Grant | $0.00 | +18.8K | 34.3K | +122% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | Freire Maria C | Dir | A - Grant | $0.00 | +18.8K | 99.3K | +23% | $0 | |
| 2024-06-04 | 2024-05-31 | EXEL | WYSZOMIERSKI JACK L | Dir | A - Grant | $0.00 | +18.8K | 357.8K | +6% | $0 | |
| MI | 2024-05-30 | 2024-05-28+ | EXEL | JOHNSON DAVID EDWARD | Dir | P - Purchase | $20.55 | +425.0K | 1.30M | +49% | +$8.73M |
| 2024-05-23 | 2024-05-21 | EXEL | Smith Julie | Dir | S - Sale | $21.12 | -27.3K | 5,445 | -83% | -$576.2K | |
| D | 2024-05-22 | 2024-05-21 | EXEL | POSTE GEORGE | Dir | S - Sale+OE | $20.96 | -11.7K | 213.9K | -5% | -$244.9K |
| D | 2024-05-22 | 2024-05-21 | EXEL | POSTE GEORGE | Dir | M - OptEx | $19.57 | +11.7K | 225.6K | +5% | +$228.7K |
| D | 2024-05-22 | 2024-05-20 | EXEL | PAPADOPOULOS STELIOS | Dir | M - OptEx | $19.57 | +11.7K | 1.27M | +0.9% | +$228.7K |
| D | 2024-05-22 | 2024-05-20 | EXEL | PAPADOPOULOS STELIOS | Dir | S - Sale+OE | $21.00 | -11.4K | 1.26M | -0.9% | -$240.2K |
| M | 2024-05-17 | 2024-05-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $20.99 | -73.9K | 1.00M | -7% | -$1.55M |
| M | 2024-05-17 | 2024-05-15 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $20.99 | -25.9K | 630.3K | -4% | -$544.5K |
| M | 2024-05-17 | 2024-05-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $20.99 | -30.3K | 721.7K | -4% | -$636.2K |
| M | 2024-05-17 | 2024-05-15 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $20.99 | -22.6K | 529.6K | -4% | -$474.5K |
| M | 2024-05-17 | 2024-05-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $20.99 | -31.0K | 355.0K | -8% | -$651.6K |
| D | 2024-05-15 | 2024-05-13 | EXEL | WYSZOMIERSKI JACK L | Dir | M - OptEx | $19.57 | +11.7K | 349.9K | +3% | +$228.7K |
| D | 2024-05-15 | 2024-05-13 | EXEL | WYSZOMIERSKI JACK L | Dir | S - Sale+OE | $21.37 | -10.9K | 338.9K | -3% | -$233.4K |
| D | 2024-03-25 | 2024-03-21 | EXEL | Garber Alan M | Dir | S - Sale+OE | $24.01 | -19.2K | 35.7K | -35% | -$461.1K |
| D | 2024-03-25 | 2024-03-21 | EXEL | Garber Alan M | Dir | M - OptEx | $19.57 | +23.5K | 54.9K | +75% | +$459.7K |
| 2024-02-27 | 2024-02-23 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +63.4K | 542.4K | +13% | $0 | |
| 2024-02-27 | 2024-02-23 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $21.45 | -47.0K | 384.9K | -11% | -$1.01M | |
| 2024-02-27 | 2024-02-23 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +63.4K | 431.9K | +17% | $0 | |
| 2024-02-27 | 2024-02-23 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | A - Grant | $0.00 | +63.4K | 655.1K | +11% | $0 | |
| 2024-02-27 | 2024-02-23 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +82.1K | 752.0K | +12% | $0 | |
| 2024-02-27 | 2024-02-23 | EXEL | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | A - Grant | $0.00 | +82.1K | 322.1K | +34% | $0 | |
| 2024-02-27 | 2024-02-23 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +241.7K | 1.04M | +30% | $0 | |
| I | 2024-02-22 | 2024-02-21 | EXEL | Caligan Partners LP | Dir, See Remarks | P - Purchase | $20.70 | +190.0K | 1.10M | +21% | +$3.93M |
| 2024-02-16 | 2024-02-15 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $20.39 | -10.6K | 479.0K | -2% | -$216.7K | |
| 2024-01-16 | 2024-01-11 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +63.2K | 501.3K | +14% | $0 | |
| 2024-01-16 | 2024-01-11 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $22.86 | -11.6K | 489.7K | -2% | -$265.3K | |
| 2024-01-16 | 2024-01-11 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $22.86 | -21.9K | 669.9K | -3% | -$499.8K | |
| 2024-01-16 | 2024-01-11 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +80.2K | 691.7K | +13% | $0 | |
| 2024-01-16 | 2024-01-11 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +250.4K | 860.4K | +41% | $0 | |
| 2024-01-16 | 2024-01-11 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $22.86 | -63.7K | 796.7K | -7% | -$1.46M | |
| 2024-01-16 | 2024-01-11 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $22.86 | -13.1K | 591.7K | -2% | -$298.6K | |
| 2024-01-16 | 2024-01-11 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | A - Grant | $0.00 | +71.4K | 604.8K | +13% | $0 | |
| 2024-01-16 | 2024-01-11 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +74.5K | 382.1K | +24% | $0 | |
| 2024-01-16 | 2024-01-11 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $22.86 | -13.6K | 368.5K | -4% | -$311.2K | |
| D | 2024-01-09 | 2024-01-05 | EXEL | Beckerle Mary C | Dir | A - Grant | $0.00 | +15.4K | 15.4K | New | $0 |
| D | 2024-01-09 | 2024-01-05 | EXEL | Eckhardt Sue Gail | Dir | A - Grant | $0.00 | +15.4K | 15.4K | New | $0 |
| 2023-12-14 | 2023-12-13 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale | $23.01 | -25.0K | 533.3K | -4% | -$575.2K | |
| DM | 2023-12-14 | 2023-12-12+ | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale+OE | $23.16 | -64.1K | 307.7K | -17% | -$1.49M |
| D | 2023-12-14 | 2023-12-14 | EXEL | Haley Patrick J. | EVP, Commercial | M - OptEx | $16.29 | +50.0K | 357.7K | +16% | +$814.5K |
| M | 2023-12-04 | 2023-11-30+ | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale | $22.04 | -50.0K | 558.3K | -8% | -$1.10M |
| I | 2023-11-29 | 2023-11-27 | EXEL | Caligan Partners LP | Dir | S - Sale | $21.61 | -120.4K | 790.3K | -13% | -$2.60M |
| I | 2023-11-29 | 2023-11-27 | EXEL | Caligan Partners LP | Dir | P - Purchase | $21.61 | +120.4K | 910.7K | +15% | +$2.60M |
| I | 2023-11-20 | 2023-11-16 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -19.0K | 1.44M | -1% | $0 |
| 2023-11-09 | 2023-11-07 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -116.9K | 610.0K | -16% | $0 | |
| I | 2023-11-09 | 2023-11-07 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | +116.9K | 1.46M | +9% | $0 |
| 2023-09-08 | 2023-09-06 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $22.27 | -14.4K | 608.3K | -2% | -$319.7K | |
| 2023-09-08 | 2023-09-06 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | A - Grant | $0.00 | +57.9K | 622.7K | +10% | $0 | |
| 2023-09-08 | 2023-09-06 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +65.1K | 628.7K | +12% | $0 | |
| 2023-09-08 | 2023-09-06 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $22.27 | -17.1K | 611.5K | -3% | -$381.9K | |
| 2023-09-08 | 2023-09-06 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +50.7K | 450.6K | +13% | $0 | |
| 2023-09-08 | 2023-09-06 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $22.27 | -12.6K | 438.0K | -3% | -$279.7K | |
| 2023-09-08 | 2023-09-06 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $22.27 | -46.6K | 726.9K | -6% | -$1.04M | |
| 2023-09-08 | 2023-09-06 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +188.0K | 773.5K | +32% | $0 | |
| 2023-09-08 | 2023-09-06 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $22.27 | -14.4K | 321.8K | -4% | -$319.7K | |
| 2023-09-08 | 2023-09-06 | EXEL | Haley Patrick J. | EVP, Commercial | A - Grant | $0.00 | +57.9K | 336.2K | +21% | $0 | |
| MI | 2023-09-05 | 2023-08-31+ | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -1,279 | 1.40M | -0.1% | $0 |
| 2023-09-05 | 2023-08-31 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | G - Gift | $0.00 | -56.2K | 585.5K | -9% | $0 | |
| 2023-09-01 | 2023-08-30 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $22.47 | -4,600 | 399.9K | -1% | -$103.4K | |
| D | 2023-08-30 | 2023-08-28 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $22.18 | -303.8K | 641.7K | -32% | -$6.74M |
| D | 2023-08-30 | 2023-08-28 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | M - OptEx | $15.31 | +360.0K | 945.5K | +61% | +$5.51M |
| D | 2023-08-25 | 2023-08-24 | EXEL | Peterson Amy C. | CMO, EVP Prod Dev, Med Aff | A - Grant | $0.00 | +240.0K | 240.0K | New | $0 |
| 2023-08-17 | 2023-08-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $21.51 | -23.3K | 585.5K | -4% | -$501.3K | |
| 2023-08-17 | 2023-08-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $21.51 | -8,074 | 563.6K | -1% | -$173.7K | |
| 2023-08-17 | 2023-08-15 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $21.51 | -7,177 | 564.8K | -1% | -$154.4K | |
| 2023-08-17 | 2023-08-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $21.51 | -7,177 | 278.3K | -3% | -$154.4K | |
| 2023-08-17 | 2023-08-15 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $21.51 | -6,280 | 404.5K | -2% | -$135.1K | |
| 2023-08-07 | 2023-08-03 | EXEL | Haley Patrick J. | EVP, Commercial | S - Sale | $20.67 | -30.6K | 285.5K | -10% | -$631.5K | |
| DM | 2023-08-07 | 2023-08-03+ | EXEL | Senner Christopher J. | EVP, CFO | M - OptEx | $14.74 | +120.0K | 631.6K | +23% | +$1.77M |
| DM | 2023-08-07 | 2023-08-03+ | EXEL | Senner Christopher J. | EVP, CFO | S - Sale+OE | $20.59 | -120.0K | 571.6K | -17% | -$2.47M |
| D | 2023-08-03 | 2023-08-01 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | M - OptEx | $14.74 | +55.7K | 627.7K | +10% | +$821.2K |
| D | 2023-08-03 | 2023-08-01 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale+OE | $19.63 | -55.7K | 572.0K | -9% | -$1.09M |
| D | 2023-06-02 | 2023-05-31 | EXEL | Oliver Bob | Dir | A - Grant | $0.00 | +18.2K | 18.2K | New | $0 |
| 2023-06-02 | 2023-06-01 | EXEL | PAPADOPOULOS STELIOS | Dir | A - Grant | $0.00 | +20.7K | 1.26M | +2% | $0 | |
| 2023-06-02 | 2023-06-01 | EXEL | WYSZOMIERSKI JACK L | Dir | A - Grant | $0.00 | +20.7K | 338.2K | +7% | $0 | |
| D | 2023-06-02 | 2023-05-31 | EXEL | Heyman Tomas J. | Dir | A - Grant | $0.00 | +18.2K | 18.2K | New | $0 |
| 2023-06-02 | 2023-06-01 | EXEL | POSTE GEORGE | Dir | A - Grant | $0.00 | +20.7K | 213.9K | +11% | $0 | |
| 2023-06-02 | 2023-06-01 | EXEL | Freire Maria C | Dir | A - Grant | $0.00 | +20.7K | 80.4K | +35% | $0 | |
| D | 2023-06-02 | 2023-05-31 | EXEL | Caligan Partners LP | Dir, See Remarks | A - Grant | $0.00 | +18.2K | 18.2K | New | $0 |
| 2023-06-02 | 2023-06-01 | EXEL | Wright Jacqueline | Dir | A - Grant | $0.00 | +20.7K | 51.8K | +67% | $0 | |
| M | 2023-05-17 | 2023-05-15 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | F - Tax | $19.18 | -12.0K | 579.0K | -2% | -$229.5K |
| M | 2023-05-17 | 2023-05-15 | EXEL | Haley Patrick J. | EVP, Commercial | F - Tax | $19.18 | -18.1K | 316.0K | -5% | -$346.5K |
| M | 2023-05-17 | 2023-05-15 | EXEL | Senner Christopher J. | EVP, CFO | F - Tax | $19.18 | -18.4K | 571.6K | -3% | -$353.8K |
| 2023-05-17 | 2023-05-15 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | F - Tax | $19.18 | -33.5K | 608.8K | -5% | -$642.9K | |
| M | 2023-05-17 | 2023-05-15 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $19.18 | -10.5K | 416.9K | -2% | -$201.2K |
| 2023-04-05 | 2023-04-03 | EXEL | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +68.3K | 419.8K | +19% | $0 | |
| D | 2023-04-05 | 2023-04-03 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | A - Grant | $0.00 | +79.7K | 607.4K | +15% | $0 |
| D | 2023-04-05 | 2023-04-05 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | S - Sale+OE | $20.01 | -38.9K | 582.4K | -6% | -$779.0K |
| D | 2023-04-05 | 2023-04-05 | EXEL | Hessekiel Jeffrey | EVP, GC, Sec | M - OptEx | $14.74 | +13.9K | 621.4K | +2% | +$205.3K |
| 2023-04-05 | 2023-04-03 | EXEL | MORRISSEY MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +313.2K | 642.3K | +95% | $0 | |
| 2023-04-05 | 2023-04-03 | EXEL | Senner Christopher J. | EVP, CFO | A - Grant | $0.00 | +85.4K | 590.1K | +17% | $0 | |
| 2023-04-05 | 2023-04-03 | EXEL | Goodman Vicki L | EVP, CMO, Prod Dev, Med Aff | A - Grant | $0.00 | +82.6K | 307.7K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations